The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
The role of BRCA1 in DNA damage response
Open accessAbstract
BRCA1 is a well-established tumor suppressor gene, which is frequently mutated in familial breast and ovarian cancers. The gene product of BRCA1 functions in a number of cellular pathways that maintain genomic stability, including DNA damage-induced cell cycle checkpoint activation, DNA damage repair, protein ubiquitination, chromatin remodeling, as well as transcriptional regulation and apoptosis. In this review, we discuss recent advances regarding our understanding of the role of BRCA1 in tumor suppression and DNA damage response, including DNA damage-induced cell cycle checkpoint activation and DNA damage repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Evidence suggests that BRCA1 could be one of the key players in DNA damage response [281].”
From Molecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair (2010) · cites this paper as [281]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Checkpoints: Controls That Ensure the Order of Cell Cycle Events
Hartwell, L. H., & Weinert, T. A. (1989) · Science · doi:10.1126/science.2683079 · Cited by 3,053
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., & Chen, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100466200 · Cited by 1,954
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B., Walsh, W., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex
Lee, J.-H., & Paull, T. T. (2005) · Science · doi:10.1126/science.1108297 · Cited by 1,424
BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L., Haugen-Strano, A., Swensen, J., & Miki, Y. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,378
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
RNF8 Ubiquitylates Histones at DNA Double-Strand Breaks and Promotes Assembly of Repair Proteins
Mailand, N., Bekker‐Jensen, S., Kildegaard, H. F., Melander, F., Bártek, J., Lukas, C., & Lukas, J. (2007) · Cell · doi:10.1016/j.cell.2007.09.040 · Cited by 1,193
Stucki, M., Clapperton, J. A., Mohammad, D. H., Yaffe, M. B., Smerdon, S. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.038 · Cited by 1,164
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
RNF8 Transduces the DNA-Damage Signal via Histone Ubiquitylation and Checkpoint Protein Assembly
Huen, M. S. Y., Grant, R. A., Manke, I. A., Minn, K. T., Yu, X., Yaffe, M. B., & Chen, J. (2007) · Cell · doi:10.1016/j.cell.2007.09.041 · Cited by 1,068
Self-citationMolecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 977
Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase
Kolas, N. K., Chapman, J. R., Nakada, S., Ylanko, J., Chahwan, R., Sweeney, F. D., Panier, S., Mendez, M., Wildenhain, J., Thomson, T. M., et al. (2007) · Science · doi:10.1126/science.1150034 · Cited by 932
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
The BRCT Domain Is a Phospho-Protein Binding Domain
Yu, X., Chini, C. C. S., He, M., Mer, G., & Chen, J. (2003) · Science · doi:10.1126/science.1088753 · Cited by 862
Self-citationControl of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Self-citationATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
Lim, D.-S., Kim, S.-T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H. J., & Kastan, M. B. (2000) · Nature · doi:10.1038/35007091 · Cited by 786
Xu, X., Wagner, K., Larson, D. M., Ohler, Z. W., Li, C., Ried, T., Hennighausen, L. G., Wynshaw-Boris, A. J., & Deng, C. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 766
Direct Activation of the ATM Protein Kinase by the Mre11/Rad50/Nbs1 Complex
Lee, J.-H., & Paull, T. T. (2004) · Science · doi:10.1126/science.1091496 · Cited by 762
RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites
Sobhian, B., Shao, G., Lilli, D. R., Culhane, A. C., Moreau, L. A., Xia, B., Livingston, D. M., & Greenberg, R. A. (2007) · Science · doi:10.1126/science.1139516 · Cited by 697
Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response
Wang, B., Matsuoka, S., Ballif, B. A., Zhang, D., Smogorzewska, A., Gygi, S. P., & Elledge, S. J. (2007) · Science · doi:10.1126/science.1139476 · Cited by 695
BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting
Manke, I. A., Lowery, D. M., Nguyen, A., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1088877 · Cited by 651
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Sy, S. M.-H., Huen, M. S. Y., & Chen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811159106 · Cited by 643
The impact of a negligent G2/M checkpoint on genomic instability and cancer induction
Löbrich, M., & Jeggo, P. A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2248 · Cited by 640
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
DNA MISMATCH REPAIR AND GENETIC INSTABILITY
Harfe, B. D., & Jinks-Robertson, S. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.359 · Cited by 605
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B., & Yu, X. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.018 · Cited by 575
Self-citationInvolvement of Brca1 in S-Phase and G 2 -Phase Checkpoints after Ionizing Irradiation
Xu, B., Kim, S., & Kastan, M. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3445-3450.2001 · Cited by 550
Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response
Kim, H., Chen, J., & Yu, X. (2007) · Science · doi:10.1126/science.1139621 · Cited by 540
Self-citationBernstein, C. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00009-1 · Cited by 527
DNA Damage ResponsePreprint
Giglia‐Mari, G., Zotter, A., & Vermeulen, W. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000745 · Cited by 525
SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpointPreprint
Yazdi, P. T., Wang, Y., Zhao, S., Patel, N., Lee, E. Y.-H. P., & Qin, J. (2002) · Genes & Development · doi:10.1101/gad.970702 · Cited by 519
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
Yarden, R. I., Pardo-Reoyo, S., Sgagias, M. K., Cowan, K. H., & Brody, L. C. (2002) · Nature Genetics · doi:10.1038/ng837 · Cited by 483
Liu, X., Holstege, H. H., van der Gulden, H. M. L., Treur-Mulder, M., Zevenhoven, J., Velds, A., Kerkhoven, R. M., van Vliet, M. H., Wessels, L. F. A., Peterse, J. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702969104 · Cited by 476
Zhao, H., Watkins, J. L., & Piwnica-Worms, H. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182557299 · Cited by 472
Evidence for a transcriptional activation function of BRCA1 C-terminal region
Monteiro, Á. N. A., August, A., & Hanafusa, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13595 · Cited by 447
Dasika, G. K., Lin, S.-C. J., Zhao, S., Sung, P., Tomkinson, A., & Lee, E. Y.-H. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203283 · Cited by 427
Yu, X., & Chen, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9478-9486.2004 · Cited by 410
Self-citationChk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation
O’Connell, M. J., Raleigh, J., Verkade, H. M., & Nurse, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.3.545 · Cited by 398
PARP-1, a determinant of cell survival in response to DNA damage
Bouchard, V. J., Rouleau, M., & Poirier, G. G. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00083-3 · Cited by 390
The G2-phase DNA-damage checkpoint
O’Connell, M. J., Walworth, N. C., & Carr, A. M. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01773-6 · Cited by 385
Jeggo, P. A. (1998) · Advances in genetics · doi:10.1016/s0065-2660(08)60144-3 · Cited by 362
Genetic Analysis of BRCA1 Function in a Defined Tumor Cell Line
Scully, R., Ganesan, S., Vlasakova, K., Chen, J., Socolovsky, M., & Livingston, D. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80238-5 · Cited by 359
Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes
Greenberg, R. A., Sobhian, B., Pathania, S., Cantor, S. B., Nakatani, Y., & Livingston, D. M. (2006) · Genes & Development · doi:10.1101/gad.1381306 · Cited by 308
PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
Zhang, F., Fan, Q., Ren, K., & Andreassen, P. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0123 · Cited by 303
Paull, T. T., Cortez, D., Bowers, B., Elledge, S. J., & Gellert, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111125998 · Cited by 282
A subset of ATM‐ and ATR‐dependent phosphorylation events requires the BRCA1 protein
Foray, N., Marot, D., Gabriel, A., Randrianarison-Huetz, V., Carr, A. M., Perricaudet, M., Ashworth, A., & Jeggo, P. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg274 · Cited by 266
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
Evers, B., & Jonkers, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209871 · Cited by 264
Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.Preprint
Rhind, N., Furnari, B. A., & Russell, P. R. (1997) · Genes & Development · doi:10.1101/gad.11.4.504 · Cited by 256
PARP inhibitors for cancer therapy
Curtin, N. J. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940500904x · Cited by 238
Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains
Rodriguez, M., Yu, X., Chen, J., & Songyang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300407200 · Cited by 234
Self-citationA Critical Role for the Ubiquitin-Conjugating Enzyme Ubc13 in Initiating Homologous Recombination
Zhao, G., Sonoda, E., Barber, L. J., Oka, H., Murakawa, Y., Yamada, K., Ikura, T., Wang, X., Kobayashi, M., Yamamoto, K., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.029 · Cited by 220
Location of BRCA1 in Human Breast and Ovarian Cancer Cells
Scully, R., Ganesan, S., Brown, M. A., Caprio, J. A. D., Cannistra, S. A., Feunteun, J., Schnitt, S. J., & Livingston, D. M. (1996) · Science · doi:10.1126/science.272.5258.123 · Cited by 217
CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response
Kim, H., Huang, J., & Chen, J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1277 · Cited by 212
Regulatory ubiquitylation in response to DNA double-strand breaks
Panier, S., & Durocher, D. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.013 · Cited by 203
Snouwaert, J. N., Gowen, L. C., Latour, A. M., Mohn, A. R., Xiao, A., DiBiase, L., & Koller, B. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203334 · Cited by 197
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
Purnomosari, D., Pals, G., Wahyono, A., Aryandono, T., Manuaba, T. W., Haryono, S. J., & van Diest, P. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9493-4 · Cited by 197
Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair
Bolderson, E., Richard, D. J., Zhou, B. S., & Khanna, K. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0096 · Cited by 194
Fu, Y., Yu, J., Cheng, T., Lou, M., Hsu, G., Wu, C., Chen, S.-T., Wu, H., Wu, P., & Shen, C. (2003) · PubMed · Cited by 181
Wang, B., Hurov, K., Hofmann, K., & Elledge, S. J. (2009) · Genes & Development · doi:10.1101/gad.1770309 · Cited by 172
Fabbro, M., Savage, K. I., Hobson, K., Deans, A. J., Powell, S. N., McArthur, G. A., & Khanna, K. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405372200 · Cited by 169
MERIT40 facilitates BRCA1 localization and DNA damage repairPreprint
Feng, L., Huang, J., & Chen, J. (2009) · Genes & Development · doi:10.1101/gad.1770609 · Cited by 163
Breast Cancer Susceptibility Genes: BRCA1 and BRCA2
Brody, L. C., & Biesecker, B. B. (1998) · Medicine · doi:10.1097/00005792-199805000-00006 · Cited by 161
BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks
Zhong, Q., Chen, C., Chen, P., & Lee, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200748200 · Cited by 155
Reed, S. I., Bailly, É., Dulić, V., Hengst, L., Resnitzky, D., & Slingerland, J. M. (1994) · Journal of Cell Science · doi:10.1242/jcs.1994.supplement_18.10 · Cited by 155
MERIT40 controls BRCA1–Rap80 complex integrity and recruitment to DNA double-strand breaksPreprint
Shao, G., Patterson-Fortin, J., Messick, T. E., Feng, D., Shanbhag, N. M., Wang, Y., & Greenberg, R. A. (2009) · Genes & Development · doi:10.1101/gad.1739609 · Cited by 153
Histone Ubiquitination Associates with BRCA1-Dependent DNA Damage Response
Wu, J., Huen, M. S. Y., Lu, L., Lin, Y., Dou, Y., Ljungman, M. E., Chen, J., & Yu, X. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01302-08 · Cited by 152
Self-citationCCDC98 targets BRCA1 to DNA damage sites
Liu, Z., Wu, J., & Yu, X. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1279 · Cited by 148
Self-citationA mouse model of basal‐like breast carcinoma with metaplastic elements
McCarthy, A., Savage, K., Gabriel, A., Naceur‐Lombardelli, C., Reis‐Filho, J., & Ashworth, A. (2007) · The Journal of Pathology · doi:10.1002/path.2124 · Cited by 144
BRCA1 RING Domain Cancer-predisposing Mutations
Brzović, P. S., Meza, J. E., King, M., & Klevit, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106551200 · Cited by 135
Bau, D., Fu, Y., Chen, S.-T., Cheng, T., Yu, J.-C., Wu, P.-E., & Shen, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0403 · Cited by 126
Shakya, R., Szabolcs, M. J., McCarthy, E. E., Ospina, E., Basso, K., Nandula, S. V., Murty, V. V., Baer, R. J., & Ludwig, T. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711032105 · Cited by 125
Wang, H., Zeng, Z., Bui, T. A., DiBiase, S. J., Qin, W., Xia, F., Powell, S. N., & Iliakis, G. E. (2001) · PubMed · Cited by 119
Epidemiology, prevention, and early detection of breast cancer
Daudt, A. W., Alberg, A. J., & Helzlsouer, K. J. (1996) · Current Opinion in Oncology · doi:10.1097/00001622-199611000-00003 · Cited by 116
Radioresistant DNA synthesis: an intrinsic feature of ataxia telangiectasia
Painter, R. B. (1981) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(81)90061-0 · Cited by 115
Structural Consequences of a Cancer-causing BRCA1-BRCT Missense Mutation
Williams, R. S., & Glover, J. N. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210019200 · Cited by 101
A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining
Baldeyron, C., Jacquemin, E., Smith, J., Jacquemont, C. F., Oliveira, I. D., Gad, S., Feunteun, J., Stoppa‐Lyonnet, D., & Papadopoulo, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205200 · Cited by 99
Cell-cycle responses to DNA damage in G2
Cuddihy, A. R., & O'Connell, M. J. (2003) · International Review of Cytology · doi:10.1016/s0074-7696(02)22013-6 · Cited by 89
Brca1 required for T cell lineage development but not TCR loci rearrangement
Mak, T. W., Hakem, A., McPherson, J., Shehabeldin, A., Zablocki, E., Migon, E., Duncan, G., Bouchard, D., Wakeham, A., Cheung, A., et al. (2000) · Nature Immunology · doi:10.1038/76950 · Cited by 86
The role of BRCA1 in non-homologous end-joining
Bau, D., Mau, Y.-C., & Shen, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.08.003 · Cited by 65
Independence of R/M/N Focus Formation and the Presence of Intact BRCA1
Wu, X. (2000) · Science · doi:10.1126/science.289.5476.11a · Cited by 61
Tumor formation in Brca1 conditional mutant mice
Deng, C. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10069 · Cited by 60
Epidemiology, prevention, and early detection of breast cancer
Alberg, A. J., & Helzlsouer, K. J. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00003 · Cited by 54
Breast Cancer Susceptibility Genes
Lubiński, J., Korzeń, M., Górski, B., Cybulski, C., Dębniak, T., Jakubowska, A., Mędrek, K., Matyjasik, J., Huzarski, T., Byrski, T., et al. (2012) · SpringerReference · doi:10.1007/springerreference_178275 · Cited by 43
Coupier, I., Baldeyron, C., Rousseau, A., Mosseri, V., Pagès-Berhouet, S., Caux‐Moncoutier, V., Papadopoulo, D., & Stoppa‐Lyonnet, D. (2003) · Oncogene · doi:10.1038/sj.onc.1207191 · Cited by 37
Jeng, Y., CAI-NG, S., Li, A., Furuta, S., Chew, H., Chen, P.-L., Lee, E.-Y.-H., & Lee, W.-H. (2007) · Oncogene · doi:10.1038/sj.onc.1210451 · Cited by 36
S phase damage sensing checkpoints in mammalian cells.
Jm, L., Lee, H., & Hamlin, J. L. (1997) · PubMed · Cited by 34
Mouse models for BRCA1 associated tumorigenesis: From fundamental insights to preclinical utility
Bouwman, P., & Jonkers, J. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6266 · Cited by 26
Shorrocks, J., Tobi, S., Latham, H., Peacock, J. H., Eeles, R. A., Eccles, D., & McMillan, T. J. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.042 · Cited by 19
Interactions of the Nijmegen Breakage Syndrome Protein with ATM and BRCA1Preprint
Wu, X., Rathbun, G. A., Lane, W. S., Weaver, D. T., & Livingston, D. M. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.535 · Cited by 8
[Postgastrectomy small intestine adhesions].
Murakami, T., & Kawasaki, T. (1975) · PubMed · Cited by 1
Flagged first, then by citations
Cited by
Sorted by citations
Molecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair
Rastogi, R. P., Richa, Kumar, A., Tyagi, M. B., & Sinha, R. P. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/592980 · Cited by 1,329
Gadd45 in Stress Signaling, Cell Cycle Control, and Apoptosis
Salvador, J. M., Brown-Clay, J. D., & Fornace, A. J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-8289-5_1 · Cited by 402
Mittal, S., Kaur, H., Gautam, N., & Mantha, A. K. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.028 · Cited by 295
Irianto, J., Xia, Y., Pfeifer, C. R., Athirasala, A., Ji, J., Alvey, C. M., Tewari, M., Bennett, R. R., Harding, S. M., Liu, A. J., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.11.049 · Cited by 289
Exploitation of EP300 and CREBBP Lysine Acetyltransferases by CancerPreprint
Attar, N., & Kurdistani, S. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026534 · Cited by 237
Metadata
- Authors
- Wu, J., Lu, L.-Y., & Yu, X.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Yu, Xiaochun
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02
- Volume
- 1
- Issue
- 2
- Pages
- 117-123
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- PMC
- PMC3078634
- OpenAlex
- W2140930673
- Cited by
- 235
- References
- 100
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 25 · 2023: 17 · 2022: 32 · 2021: 20 · 2020: 15 · 2019: 18 · 2018: 16 · 2017: 9 · 2016: 15 · 2015: 9 · 2014: 13 · 2013: 15 · 2012: 9
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Protein & Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Michigan
- National Institutes of Health
- National Cancer Institute (R01CA132755, R01CA130899, CA132755)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, DNA damage response, tumor suppression, DNA repair, genome stability, ubiquitination, chromatin remodeling, transcriptional regulation, apoptosis, breast cancer, ovarian cancer
- MeSH terms
- Breast Neoplasms, DNA Damage, DNA Repair, Female, Humans, Mutation, Ovarian Neoplasms, Signal Transduction, Genes, Tumor Suppressor, Apoptosis, Genes, cdc, BRCA1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review